DrugPatentWatch Database Preview
Pharmacia Company Profile
» See Plans and Pricing
What is the competitive landscape for PHARMACIA, and what generic alternatives to PHARMACIA drugs are available?
PHARMACIA has one hundred and thirteen approved drugs.
There are two US patents protecting PHARMACIA drugs.
There are sixty-two patent family members on PHARMACIA drugs in thirty-four countries and seventy-two supplementary protection certificates in fourteen countries.
Summary for Pharmacia
| International Patents: | 62 |
| US Patents: | 2 |
| Tradenames: | 91 |
| Ingredients: | 74 |
| NDAs: | 113 |
Drugs and US Patents for Pharmacia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | PROSTIN VR PEDIATRIC | alprostadil | INJECTABLE;INJECTION | 018484-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Pharmacia And Upjohn | NORMIFLO | ardeparin sodium | INJECTABLE;INJECTION | 020227-002 | May 23, 1997 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Pharmacia And Upjohn | NEO-CORTEF | hydrocortisone acetate; neomycin sulfate | SUSPENSION/DROPS;OPHTHALMIC | 060612-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Pharmacia And Upjohn | ALPHADROL | fluprednisolone | TABLET;ORAL | 012259-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Pharmacia And Upjohn | TYMTRAN | ceruletide diethylamine | INJECTABLE;INJECTION | 018296-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pharmacia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-006 | Jan 30, 2004 | 4,681,893*PED | Start Trial |
| Pharmacia And Upjohn | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-001 | May 26, 1995 | 4,963,551 | Start Trial |
| Pharmacia And Upjohn | PROSTIN E2 | dinoprostone | SUPPOSITORY;VAGINAL | 017810-001 | Approved Prior to Jan 1, 1982 | 3,598,858 | Start Trial |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-008 | Jan 30, 2004 | 6,455,574 | Start Trial |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-002 | Jan 30, 2004 | 6,126,971*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PHARMACIA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 10 mg/10 mg, 10 mg/20 mg and 10 mg/80 mg | ➤ Subscribe | 2006-12-29 |
| ➤ Subscribe | Tablets | 2.5 mg/40 mg | ➤ Subscribe | 2009-09-17 |
| ➤ Subscribe | Tablets | 5 mg/80 mg | ➤ Subscribe | 2009-04-07 |
| ➤ Subscribe | Tablets | 1 g | ➤ Subscribe | 2005-08-23 |
International Patents for Pharmacia Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 152537 | Start Trial |
| New Zealand | 517039 | Start Trial |
| European Patent Office | 1200065 | Start Trial |
| Estonia | 200200631 | Start Trial |
| Eurasian Patent Organization | 007682 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Pharmacia Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0771217 | 07C0001 | France | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804 |
| 0502314 | SPC/GB11/010 | United Kingdom | Start Trial | PRODUCT NAME: THE COMBINATION OF A) TELMISARTAN, OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS, AND B) AMLODIPINE, OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS, ESPECIALLY AMLODIPINE BESYLATE; REGISTERED: UK EU/1/10/648/001 20101007; UK EU/1/10/648/002 20101007; UK EU/1/10/648/003 20101007; UK EU/1/10/648/004 20101007; UK EU/1/10/648/005 20101007; UK EU/1/10/648/006 20101007; UK EU/1/10/648/007 20101007; UK EU/1/10/648/008 20101007; UK EU/1/10/648/009 20101007; UK EU/1/10/648/010 20101007; UK EU/1/10/648/011 20101007; UK EU/1/10/648/012 20101007; UK EU/1/10/648/013 20101007; UK EU/1/10/648/014 20101007; UK EU/1/10/648/015 20101007; UK EU/1/10/648/016 20101007; UK |
| 0584952 | 99C0004 | Belgium | Start Trial | PRODUCT NAME: ESTRADIOL, HEMIHYDRATE, NORETHISTERONE, ACETATE; NAT. REGISTRATION NO/DATE: NL 23753 19981210; FIRST REGISTRATION: SE - 14 007 19980306 |
| 0770388 | 9/2009 | Austria | Start Trial | PRODUCT NAME: KOMBINATION AUS ESTRADIOLVALERAT UND DIENOGEST; NAT. REGISTRATION NO/DATE: 1-28003 20090203; FIRST REGISTRATION: BE BE 327792 20081103 |
| 0770388 | PA2009004 | Lithuania | Start Trial | PRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
